260 related articles for article (PubMed ID: 20799032)
1. Development of new folate-based PET radiotracers: preclinical evaluation of ⁶⁸Ga-DOTA-folate conjugates.
Fani M; Wang X; Nicolas G; Medina C; Raynal I; Port M; Maecke HR
Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):108-19. PubMed ID: 20799032
[TBL] [Abstract][Full Text] [Related]
2. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of (68) Ga-labeled Pteroyl-Lys conjugates for folate receptor-targeted tumor imaging.
Zhang X; Yu Q; He Y; Zhang C; Zhu H; Yang Z; Lu J
J Labelled Comp Radiopharm; 2016 Jul; 59(9):346-53. PubMed ID: 27320312
[TBL] [Abstract][Full Text] [Related]
4. Development of a New Folate-Derived Ga-68-Based PET Imaging Agent.
Brand C; Longo VA; Groaning M; Weber WA; Reiner T
Mol Imaging Biol; 2017 Oct; 19(5):754-761. PubMed ID: 28194631
[TBL] [Abstract][Full Text] [Related]
5. Tumor targeting using 67Ga-DOTA-Bz-folate--investigations of methods to improve the tissue distribution of radiofolates.
Müller C; Vlahov IR; Santhapuram HK; Leamon CP; Schibli R
Nucl Med Biol; 2011 Jul; 38(5):715-23. PubMed ID: 21718947
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic Properties of
Larenkov A; Rakhimov M; Lunyova K; Klementyeva O; Maruk A; Machulkin A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32545327
[TBL] [Abstract][Full Text] [Related]
7. (64)Cu- and (68)Ga-Based PET Imaging of Folate Receptor-Positive Tumors: Development and Evaluation of an Albumin-Binding NODAGA-Folate.
Farkas R; Siwowska K; Ametamey SM; Schibli R; van der Meulen NP; Müller C
Mol Pharm; 2016 Jun; 13(6):1979-87. PubMed ID: 27145400
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
[TBL] [Abstract][Full Text] [Related]
9. Reduced
Boss SD; Müller C; Siwowska K; Büchel JI; Schmid RM; Groehn V; Schibli R; Ametamey SM
Bioconjug Chem; 2018 Apr; 29(4):1119-1130. PubMed ID: 29412638
[TBL] [Abstract][Full Text] [Related]
10. Folate-PEG-NOTA-Al
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
[TBL] [Abstract][Full Text] [Related]
11. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
12. Radiosynthesis and preclinical evaluation of [
Moisio O; Palani S; Virta J; Elo P; Liljenbäck H; Tolvanen T; Käkelä M; Miner MG; Herre EA; Marjamäki P; Örd T; Heinäniemi M; Kaikkonen MU; Zhang F; Srinivasarao M; Knuuti J; Low PS; Saraste A; Li XG; Roivainen A
Sci Rep; 2020 Aug; 10(1):13593. PubMed ID: 32788595
[TBL] [Abstract][Full Text] [Related]
13. Development and preclinical evaluation of new (124)I-folate conjugates for PET imaging of folate receptor-positive tumors.
AlJammaz I; Al-Otaibi B; Al-Rumayan F; Al-Yanbawi S; Amer S; Okarvi SM
Nucl Med Biol; 2014 Jul; 41(6):457-63. PubMed ID: 24776091
[TBL] [Abstract][Full Text] [Related]
14. A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β- radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative.
Müller C; Zhernosekov K; Köster U; Johnston K; Dorrer H; Hohn A; van der Walt NT; Türler A; Schibli R
J Nucl Med; 2012 Dec; 53(12):1951-9. PubMed ID: 23139086
[TBL] [Abstract][Full Text] [Related]
15. DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted 177Lu-radionuclide tumor therapy in mice.
Müller C; Struthers H; Winiger C; Zhernosekov K; Schibli R
J Nucl Med; 2013 Jan; 54(1):124-31. PubMed ID: 23236020
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting.
Müller C; Hohn A; Schubiger PA; Schibli R
Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1007-16. PubMed ID: 16763819
[TBL] [Abstract][Full Text] [Related]
17. [18F]fluoro-deoxy-glucose folate: a novel PET radiotracer with improved in vivo properties for folate receptor targeting.
Fischer CR; Müller C; Reber J; Müller A; Krämer SD; Ametamey SM; Schibli R
Bioconjug Chem; 2012 Apr; 23(4):805-13. PubMed ID: 22372827
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of isostructural Tc-99m- and Re-188-folate-Gly-Gly-Cys-Glu for folate receptor-positive tumor targeting.
Kim WH; Kim CG; Kim MH; Kim DW; Park CR; Park JY; Lee YS; Youn H; Kang KW; Jeong JM; Chung JK
Ann Nucl Med; 2016 Jun; 30(5):369-79. PubMed ID: 26993818
[TBL] [Abstract][Full Text] [Related]
19. Rapid synthesis and in vitro and in vivo evaluation of folic acid derivatives labeled with fluorine-18 for PET imaging of folate receptor-positive tumors.
Al Jammaz I; Al-Otaibi B; Amer S; Okarvi SM
Nucl Med Biol; 2011 Oct; 38(7):1019-28. PubMed ID: 21982573
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy.
Müller C; Mindt TL; de Jong M; Schibli R
Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):938-46. PubMed ID: 19183997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
